Related Experiment Videos
Mutation analysis of glucose-6-phosphate dehydrogenase (G6PD) variants in Costa Rica
Human Genetics
|August 1, 1991
Summary
Genetic analysis reveals common Glucose-6-phosphate dehydrogenase (G6PD) A- variants in Costa Rica. Specific mutations like G6PD Puerto Limón and G6PD Santamaria are identified, impacting hemolytic anemia risk.
Area of Science:
- Genetics
- Molecular Biology
- Hematology
Background:
- Glucose-6-phosphate dehydrogenase (G6PD) deficiency is prevalent in diverse populations, including Costa Rica.
- Previous reports indicate G6PD deficiency in both black and white populations within Costa Rica.
Purpose of the Study:
- To characterize specific Glucose-6-phosphate dehydrogenase (G6PD) variants found in Costa Rica.
- To investigate the molecular basis of G6PD Puerto Limón and G6PD Santamaria variants and their association with hemolytic anemia.
Main Methods:
- DNA sequencing to identify mutations in the G6PD gene.
- Analysis of nucleotide (nt) and amino acid substitutions.
- Electrophoretic mobility assessment of G6PD variants.
Main Results:
- All 28 G6PD A- samples analyzed were the common G6PD A-376G/202A type.
- G6PD Puerto Limón mutation identified as a G-to-A transition at nt 1192 (glu-to-lys substitution), linked to nonspherocytic hemolytic anemia.
- G6PD Santamaria variant confirmed in white subjects, featuring an A-to-T mutation at nt 542 superimposed on the G6PD A mutation, resulting in normal electrophoretic mobility.
Conclusions:
- Specific G6PD mutations, including G6PD Puerto Limón and G6PD Santamaria, are identified in Costa Rica.
- Mutations in certain G6PD regions are strongly associated with chronic hemolytic anemia.
- The G6PD Santamaria variant demonstrates a complex mutation pattern leading to normal electrophoretic mobility despite underlying G6PD A characteristics.